参考文献/References:
[1] Flynn RW, Macdonald TM, Murray GD, et al. Prescribing
antiplatelet medicine and subsequent events after intracere-
bral hemorrhage [J]. Stroke, 2010, 41(11): 2606-2611.
[2] Pennlert J, Eriksson M, Carlberg B, et al. Long-term risk
and predictors of recurrent stroke beyond the acute phas [J].
Stroke, 2014, 45(6): 1839-1841.
[3] CAPRIE Steering Committee. A randomised, blinded, trial of
clopidogrel versus aspirin in patients at risk of ischaemic
events (CAPRIE) [J]. Lancet, 1996, 348(9038): 1329-1339.
[4] Pennlert J, Overholser R, Asplund K, et al. Optimal timing
of anticoagulant treatment after intracerebral hemorrhage in
patients with atrial fibrillation [J]. Stroke, 2017, 48(2): 314-
320.
[5] Phan TG, Koh M, Wijdicks EF. Safety of discontinuation of
anticoagulation in patients with intracranial hemorrhage at
high thromboembolic risk [J]. Arch Neurol, 2000, 57(12):
1710-1713.
[6] Hemphill JC, 3rd, Greenberg SM, Anderson CS, et al. Gui-
delines for the management of spontaneous intracerebral
hemorrhage: a guideline for healthcare professionals from
the american heart association/american stroke association
[J]. Stroke, 2015, 46(7): 2032-2060.
[7] Steiner T, Al-Shahi Salman R, Beer R, et al. European
stroke organisation (ESO) guidelines for the management of
spontaneous intracerebral hemorrhage [J]. Int J Stroke,
2014, 9(7): 840-855.
[8] 中华医学会神经病学分会，中华医学会神经病学分会脑
血管病学组. 中国缺血性脑卒中和短暂性脑缺血发作二
级预防指南2014[J]. 中华神经科杂志，2015，48（4）：
258-273.
[9] Pennlert J, Asplund K, Carlberg B, et al. Antithrombotic
treatment following intracerebral hemorrhage in patients
with and without atrial fibrillation [J]. Stroke, 2015, 46(8):
2094-2099.
[10] Pasquini M, Charidimou A, Van Asch CJ, et al. Variation in
restarting antithrombotic drugs at hospital discharge after
intracerebral hemorrhage [J]. Stroke, 2014, 45(9): 2643-
2648.
[11] 王丽平，张新宇，樊东升. 脑出血患者服用抗血小板药物
的长期随访研究[J]. 中国医学前沿杂志（电子版），2016，
8（2）：81-84.
[12] Chong BH, Chan KH, Pong V, et al. Use of aspirin in Chi-
nese after recovery from primary intracranial haemorrhage
[J]. Thromb Haemost, 2012, 107(2): 241-247.
[13] He J, Whelton PK, Vu B, et al. Aspirin and risk of hemorr-
hagic stroke: a meta-analysis of randomized controlled
trials [J]. JAMA, 1998, 280(22): 1930-1935.
[14] Collaborative overview of randomised trials of antiplatelet
therapy--I: Prevention of death, myocardial infarction, and
stroke by prolonged antiplatelet therapy in various catego-
ries of patients. Antiplatelet Trialists' Collaboration [J].
BMJ, 1994, 308(6921): 81-106.
[15] Taylor DW, Barnett HJ, Haynes RB, et al. Low-dose and
high-dose acetylsalicylic acid for patients undergoing
carotid endarterectomy: a randomised controlled trial. ASA
and Carotid Endarterectomy (ACE) Trial Collaborators [J].
Lancet, 1999, 353(9171): 2179-2184.
[16] 徐大飞，楚 兰，李 娅，等. 脑微出血及其与抗栓治疗相
关性研究进展[J]. 中国神经免疫学和神经病学杂志，
2016，23（5）：364-367.
[17] Bejot Y, Osseby GV, Gremeaux V, et al. Changes in risk
factors and preventive treatments by stroke subtypes over
20 years: a population-based study [J]. J Neurol Sci, 2009,
287(1-2): 84-88.
[18] Bejot Y, Cordonnier C, Durier J, et al. Intracerebral hemorr-
hage profiles are changing: results from the Dijon population
based study [J]. Brain, 2013, 136(Pt 2): 658-664.
[19] Smolina K, Wright FL, Rayner M, et al. Determinants of the
decline in mortality from acute myocardial infarction in
England between 2002 and 2010: linked national database
study [J]. BMJ, 2012, 344: d8059.
[20] Bronnum Nielsen P, Larsen T B, Gorst-Rasmussen A, et al.
Intracranial hemorrhage and subsequent ischemic stroke in
patients with atrial fibrillation: a nationwide cohort study
[J]. Chest, 2015, 147(6): 1651-1658.
[21] Friberg L, Rosenqvist M, Lip GY. Evaluation of risk strati-
fication schemes for ischaemic stroke and bleeding in 182
678 patients with atrial fibrillation: the Swedish Atrial
Fibrillation cohort study [J]. Eur Heart J, 2012, 33(12):
1500-1510.
[22] Ottosen TP, Grijota M, Hansen ML, et al. Use of antithrom-
botic therapy and long-term clinical outcome among
patients surviving intracerebral hemorrhage [J]. Stroke,
2016, 47(7): 1837-1843.
[23] Murthy SB, Gupta A, Merkler AE, et al. Restarting anticoa-
gulant therapy after intracranial hemorrhage: a systematic
review and meta-analysis [J]. Stroke, 2017, 48(6): 1594-
1600.
相似文献/References:
[1]郑 涛 赵兰夫 高国栋.多囊肾尿毒症期并发脑出血综合治疗1例[J].中国临床神经外科杂志,2016,(05):320.[doi:10.13798/j.issn.1009-153X.2016.05.024]
[2]孔令舜 刘玉光.钻孔引流术治疗阿司匹林相关幕上脑出血的效果与安全性[J].中国临床神经外科杂志,2016,(03):181.[doi:10.13798/j.issn.1009-153X.2016.03.019]
[3]皮水平 刘 杰 黄前樟.长期服用抗凝药物的老年颅脑损伤患者治疗体会[J].中国临床神经外科杂志,2016,(02):117.[doi:10.13798/j.issn.1009-153X.2016.02.022]
[4]张 源 王文浩 林 洪 林俊明 黄 巍 李 君 罗 飞 胡连水.侧脑室后角穿刺术的新方法介绍[J].中国临床神经外科杂志,2016,(01):26.[doi:10.13798/j.issn.1009-153X.2016.01.009]
[5]谢 敏 周小炫 综述 吴成翰 审校.Toll样受体4与脑出血的研究进展[J].中国临床神经外科杂志,2015,(01):55.[doi:10.13798/j.issn.1009-153X.2015.01.019]
[6]王洪流,张爱明,董又坤.同时发生的双侧基底节区出血1例[J].中国临床神经外科杂志,2016,(11):736.[doi:10.13798/j.issn.1009-153X.2016.11.033]
[7]罗 明 段发亮 吴京雷 闵 强 陈晓斌 黄乔春 杨国平.神经导航下内镜手术治疗不典型自发性脑出血14例[J].中国临床神经外科杂志,2017,(01):40.[doi:10.13798/j.issn.1009-153X.2017.01.015]
[8]梁智雄 彭 岩 胡 松.预防性应用辛伐他汀对大鼠脑出血后血肿体积和神经功能的影响[J].中国临床神经外科杂志,2018,(05):331.[doi:10.13798/j.issn.1009-153X.2018.05.009]
LIANG Zhi-xiong,HU Song,PENG Yan..Effects of prophylactic application of simvastatin on hematoma volume and neurological function in rats with intracerebral hemorrhage[J].,2018,(12):331.[doi:10.13798/j.issn.1009-153X.2018.05.009]
[9]陈姣红 刘东媛 张红波 李明昌 熊晓星 陈谦学.成人出血型烟雾病围手术期护理观察[J].中国临床神经外科杂志,2018,(06):437.[doi:10.13798/j.issn.1009-153X.2018.06.020]
[10]刘 炎 杭春华.脑胶质瘤卒中误诊为脑动静脉畸形并出血1例[J].中国临床神经外科杂志,2018,(06):448.[doi:10.13798/j.issn.1009-153X.2018.06.025]